320 related articles for article (PubMed ID: 15118345)
1. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
3. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
4. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Fernández MM; Morán A; Martín ML; San Román L
Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
[TBL] [Abstract][Full Text] [Related]
6. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
[TBL] [Abstract][Full Text] [Related]
8. m-CPP, a 5-HT2C receptor agonist that modifies the perfusion pressure of the hindquarter vascular bed of anesthetized rat.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2005 Feb; 73(2):70-5. PubMed ID: 15452415
[TBL] [Abstract][Full Text] [Related]
9. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-induced brain glycogenolysis in rainbow trout (Oncorhynchus mykiss).
Pérez-Maceira JJ; Mancebo MJ; Aldegunde M
J Exp Biol; 2012 Sep; 215(Pt 17):2969-79. PubMed ID: 22875766
[TBL] [Abstract][Full Text] [Related]
11. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
12. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
13. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: involvement of angiotensin II and the 5-HT2 receptor activation.
Morán A; Velasco C; Martín ML; San Román L
Eur J Pharmacol; 1997 Jul; 330(2-3):205-11. PubMed ID: 9253955
[TBL] [Abstract][Full Text] [Related]
14. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
15. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.
Centurión D; Ortiz MI; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):983-90. PubMed ID: 11226128
[TBL] [Abstract][Full Text] [Related]
16. Further investigation of the effects of 5-hydroxytryptamine, 8-OH-DPAT and DOI to mediate contraction and relaxation responses in the intestine and emesis in Suncus murinus.
Javid FA; Afshin-Javid S; Horn CC
Eur J Pharmacol; 2018 Feb; 821():79-87. PubMed ID: 29277716
[TBL] [Abstract][Full Text] [Related]
17. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
18. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.
Kubera M; Maes M; Kenis G; Kim YK; Lasoń W
Psychiatry Res; 2005 Apr; 134(3):251-8. PubMed ID: 15892984
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine-induced vasodilator responses in the hindquarters of the anaesthetized rat, involve beta2-adrenoceptors.
Calama E; García M; Jarque MJ; Morán A; Martín ML; San Román L
J Pharm Pharmacol; 2003 Oct; 55(10):1371-8. PubMed ID: 14607019
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
Kennett GA; Trail B; Bright F
Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
